I N Nazarova - JoVE Visualize

Showing results (1-10 of 6) with videos related to

Pageof 1

Sort By:

Klinicheskaia Laboratornaia Diagnostika|May 1, 1995

[Fluorometric determination of amide protein groups]I V Shepotinovskaia, I N Nazarova, N Ia Umanskaia

Prikladnaia Biokhimiia I Mikrobiologiia|November 5, 1999

[A modification of lactoferrin isolation method]S Belizi, A P Shepelev, I A Klimova, et al.

Terapevticheskii Arkhiv|January 1, 1993

[The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma]A K Golenkov, I N Nazarova, T G Sarycheva, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|December 1, 1991

[Comparison of proliferative and immunoglobulin-secreting capacity of peripheral blood lymphocytes of healthy persons and patients with B-cell immunoproliferative diseases]A E Kopylov, L V Koval'chuk, R N Stepanenko, et al.

Gematologiia I Transfuziologiia|February 1, 1993

[The distribution of class-I HLA antigens in patients with multiple myeloma]A K Golenkov, I N Nazarova, A N Petrochenkov, et al.

Terapevticheskii Arkhiv|October 6, 2000

[Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy]A K Golenkov, E V Trifonova, E V Kataeva, et al.

Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:

Pageof 1

Klinicheskaia Laboratornaia Diagnostika|May 1, 1995

[Fluorometric determination of amide protein groups]I V Shepotinovskaia, I N Nazarova, N Ia Umanskaia

Prikladnaia Biokhimiia I Mikrobiologiia|November 5, 1999

[A modification of lactoferrin isolation method]S Belizi, A P Shepelev, I A Klimova, et al.

Terapevticheskii Arkhiv|January 1, 1993

[The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma]A K Golenkov, I N Nazarova, T G Sarycheva, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|December 1, 1991

[Comparison of proliferative and immunoglobulin-secreting capacity of peripheral blood lymphocytes of healthy persons and patients with B-cell immunoproliferative diseases]A E Kopylov, L V Koval'chuk, R N Stepanenko, et al.

Gematologiia I Transfuziologiia|February 1, 1993

[The distribution of class-I HLA antigens in patients with multiple myeloma]A K Golenkov, I N Nazarova, A N Petrochenkov, et al.

Terapevticheskii Arkhiv|October 6, 2000

[Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy]A K Golenkov, E V Trifonova, E V Kataeva, et al.

Pageof 1